Loading
Latest filing published 09 Jun 2023 for Ambrx Biopharma Inc.. Read the official filing
No signal scores available.
Our data holds just one disclosure by Kate Hermans, dated 9 June 2023, reporting a share grant in Ambrx Biopharma Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration